Mark Aldersley

4.0k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Mark Aldersley is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mark Aldersley has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Mark Aldersley's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver Disease and Transplantation (7 papers). Mark Aldersley is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Liver Disease and Transplantation (7 papers). Mark Aldersley collaborates with scholars based in United Kingdom, Spain and United States. Mark Aldersley's co-authors include Rachel M. Brown, Stephen Gough, George Abouda, Philip N. Newsome, Darren Barton, Diana Hull, Jeremy Tomlinson, Matthew J. Armstrong, Guruprasad P. Aithal and Richard Parker and has published in prestigious journals such as The Lancet, Hepatology and Gut.

In The Last Decade

Mark Aldersley

24 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

2015 1.6k citations Matthew J. Armstrong, Piers Gaunt et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Aldersley United Kingdom	13	1.5k	1.1k	590	569	349	26	2.0k
Elizabeth E. Hespenheide United States	11	2.0k 1.3×	963 0.9×	882 1.5×	443 0.8×	327 0.9×	13	2.3k
Darren Barton United Kingdom	14	1.7k 1.1×	1.3k 1.3×	619 1.0×	669 1.2×	466 1.3×	27	2.4k
Kristine Buchholtz Denmark	11	1.2k 0.8×	949 0.9×	357 0.6×	381 0.7×	314 0.9×	14	1.6k
Guillaume Lassailly France	16	1.7k 1.2×	699 0.7×	753 1.3×	611 1.1×	190 0.5×	47	2.1k
Francisco Barrera Chile	20	1.3k 0.9×	437 0.4×	697 1.2×	351 0.6×	207 0.6×	58	1.7k
Bienvenido Gra‐Oramas Cuba	5	1.7k 1.1×	912 0.9×	642 1.1×	316 0.6×	206 0.6×	5	1.8k
Licet Gonzalez‐Fabian Cuba	6	2.2k 1.5×	1.1k 1.1×	971 1.6×	390 0.7×	245 0.7×	6	2.4k
M J Farahvash Iran	8	947 0.6×	461 0.4×	334 0.6×	250 0.4×	101 0.3×	18	1.2k
Luis Calzadilla Bertot Australia	16	3.2k 2.1×	1.5k 1.4×	1.6k 2.7×	564 1.0×	378 1.1×	38	3.6k
Elnaz Ehteshami Afshar Canada	6	1.2k 0.8×	456 0.4×	371 0.6×	272 0.5×	237 0.7×	10	1.5k

Countries citing papers authored by Mark Aldersley

Since Specialization

Citations

This map shows the geographic impact of Mark Aldersley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aldersley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aldersley more than expected).

Fields of papers citing papers by Mark Aldersley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Aldersley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aldersley. The network helps show where Mark Aldersley may publish in the future.

Co-authorship network of co-authors of Mark Aldersley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Aldersley. A scholar is included among the top collaborators of Mark Aldersley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Aldersley. Mark Aldersley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruf, Murad, Marı́a Buti, Gaia Nebbia, et al.. (2025). Blood-borne virus testing in European emergency departments: current evidence and service considerations. European Journal of Public Health. 35(4). 766–773.

MacDonald, Douglas, Paul Richardson, Stephen Ryder, et al.. (2023). Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK. Liver International. 43(4). 917–927. 9 indexed citations

Williams, Jack, Peter Vickerman, Emma Page, et al.. (2022). Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom. Cost Effectiveness and Resource Allocation. 20(1). 60–60. 5 indexed citations

Hughes, Gareth, Lee D. Parker, Amy Evans, et al.. (2022). Real-world clinical effectiveness and sustainability of universal bloodborne virus testing in an urban emergency department in the UK. Scientific Reports. 12(1). 19257–19257. 10 indexed citations

Williams, Diane M., et al.. (2020). P74 Hepatitis C virus high intensity test and treat HMP leeds. Abstracts. A42.2–A43. 1 indexed citations

Gimson, Alexander, Kosh Agarwal, Mark Aldersley, et al.. (2018). Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy. Journal of Viral Hepatitis. 26(2). 231–235. 18 indexed citations

Fateen, Waleed, et al.. (2017). Patient understanding of liver cirrhosis and improvement using multimedia education. Frontline Gastroenterology. 8(3). 214–219. 35 indexed citations

Armstrong, Matthew J., Piers Gaunt, Guruprasad P. Aithal, et al.. (2015). Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. The Lancet. 387(10019). 679–690. 1554 indexed citations breakdown →

Gaunt, Piers, Guruprasad P. Aithal, Richard Parker, et al.. (2015). OC-016 Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, double-blinded, randomised, placebo-controlled phase ii trial. A9.1–A9. 3 indexed citations

10.

Dyson, Jessica, John M. Hutchinson, Lawrence E. Harrison, et al.. (2015). Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use. Journal of Hepatology. 64(1). 234–238. 61 indexed citations

11.

Armstrong, Matthew J., Piers Gaunt, Guruprasad P. Aithal, et al.. (2015). G01 : Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, doubleblinded, randomised, placebo-controlled phase II trial. Journal of Hepatology. 62. S187–S187. 11 indexed citations

12.

Hogan, Brian, Kerry Webb, Kosh Agarwal, et al.. (2011). 549 THE UK EXPERIENCE OF LIVER TRANSPLANTATION IN PATIENTS RECEIVING OPIATE REPLACEMENT THERAPY. Journal of Hepatology. 54. S224–S224. 1 indexed citations

13.

Bonney, Glenn Kunnath, Mark Aldersley, Sonal Asthana, et al.. (2009). Donor Risk Index and MELD Interactions in Predicting Long-Term Graft Survival: A Single-Centre Experience. Transplantation. 87(12). 1858–1863. 54 indexed citations

14.

Tolan, Damian, Keith M. Harris, Maria Sheridan, et al.. (2007). Periampullary diverticulum: an unusual cause of double duct obstruction. Gastrointestinal Endoscopy. 67(3). 565–567. 1 indexed citations

15.

Aldersley, Mark. (2000). No Polymorphism in the Tissue Transglutaminase Gene Detected in Coeliac Disease Patients. Scandinavian Journal of Gastroenterology. 35(1). 61–63. 14 indexed citations

16.

Hamlin, P. J., Pamela F. Jones, J.P. Leek, et al.. (1998). Assignment<footref rid="foot01"><sup>1</sup></footref> of GALGT encoding β-1,4N-acetylgalactosaminyl-transferase (GalNAc-T) and KIF5A encoding neuronal kinesin (D12S1889) to human chromosome band 12q13 by assignment to ICI YAC 26EG10 and in situ hybridization. Cytogenetic and Genome Research. 82(3-4). 267–268. 14 indexed citations

17.

Aldersley, Mark & John G. O’Grady. (1995). Hepatic Disorders. Drugs. 49(1). 83–102. 14 indexed citations

18.

Aldersley, Mark, John G. O’Grady, D. Mortiboy, et al.. (1994). Liver transplantation and de novo hepatitis B Infection. The Lancet. 343(8898). 677–678. 29 indexed citations

19.

Robertson, Duncan A., Mark Aldersley, H A Shepherd, R. Stephen Lloyd, & C. Smith. (1987). H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?. Gut. 28(8). 946–949. 48 indexed citations

20.

Robertson, Duncan A., Mark Aldersley, H A Shepherd, & C. Smith. (1987). Patterns of acid reflux in complicated oesophagitis.. Gut. 28(11). 1484–1488. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact